Lysine Production Plant DPR & Unit Setup - 2026: Machinery Cost, CapEx/OpEx, ROI and Raw Materials

Setting up a lysine production plant positions investors at a critical junction of the global amino acid and animal nutrition additives supply chain one of the most biologically essential and consistently expanding specialty fermentation product sectors driven by the foundational role of lysine as the first-limiting essential amino acid in swine and poultry diets where it cannot be synthesized endogenously and must be supplemented through feed to enable maximum growth performance, feed conversion efficiency, and protein deposition, sustained demand from the global expansion of intensive commercial livestock production systems serving the world's growing appetite for affordable poultry and pork protein, critical applications in precision livestock nutrition programs designed to reduce total dietary protein content while maintaining or improving animal performance by supplementing specific limiting amino acids, growing adoption of lysine as a human food fortification ingredient, pharmaceutical formulation excipient, and nutraceutical supplement active, and the large and expanding base of commercial feed manufacturers, integrated poultry and swine producers, and amino acid trading companies worldwide requiring reliable regional supply of specification-grade lysine monohydrochloride and lysine sulfate meeting stringent amino acid purity, assay, moisture, and microbiological quality requirements for high-volume livestock feed additive and specialty nutrition applications.

Market Overview and Growth Potential:

The global lysine market is experiencing strong growth, driven by rising demand for animal feed additives, increasing meat consumption across emerging economies, advancements in microbial fermentation technology improving production efficiency, and growing focus on improving livestock productivity and feed efficiency in intensifying commercial animal production systems. The lysine market size was valued at USD 6.00 Billion in 2025. According to IMARC Group estimates, the market is expected to reach USD 10.31 Billion by 2034, exhibiting a CAGR of 6.2% from 2026 to 2034. India's milk production reached 247.87 million tonnes in 2024-25, reflecting sustained growth in dairy production that is increasing demand for high-quality animal nutrition, where lysine plays a vital role in improving feed efficiency, supporting livestock productivity, and enhancing overall protein intake in dairy operations and ruminant feed programs. The steady expansion of the global livestock and animal feed industries, particularly in emerging economies where meat consumption continues to rise as incomes grow and dietary preferences shift toward higher animal protein intake, is the primary structural growth driver for lysine demand across commercial poultry, swine, and aquaculture production systems. The shift toward industrialized farming practices with precision nutrition programs optimizing amino acid supply in compound feed formulations has further strengthened demand for supplemental lysine, with increasing awareness of the nitrogen reduction and environmental sustainability benefits achievable through ideal protein formulation using synthetic amino acid supplements driving progressive adoption even in markets traditionally reliant on high-protein ingredient-based feed formulation approaches.

Request for Sample Report: https://www.imarcgroup.com/lysine-manufacturing-plant-project-report/requestsample

Lysine (L-lysine, chemical formula C6H14N2O2) is an essential amino acid that plays a critical role in protein synthesis, body growth, tissue repair, calcium absorption and bone development, enzyme and hormone production, and immune system function across all vertebrate species including livestock, poultry, aquaculture species, and humans. Since monogastric animals including swine and poultry lack the metabolic enzymatic pathways required to synthesize lysine from precursor amino acids, it is classified as nutritionally essential and must be provided in adequate quantities through the diet for achievement of genetic growth potential and optimal reproductive and immune performance. Industrially, lysine is produced by high-yielding strains of Corynebacterium glutamicum or Escherichia coli through large-scale aerobic submerged fermentation using glucose syrup or sucrose from corn or sugarcane as the primary carbon source, yielding fermentation broths containing 100 to 180 grams per liter of L-lysine that are subsequently processed through cell separation, purification, concentration, crystallization or spray drying, and packaging to produce the commercial lysine monohydrochloride (98.5% assay minimum) and lysine sulfate product forms used in compound feed formulation and specialty nutrition applications.

The lysine market is fueled by the global animal production industry's fundamental reliance on supplemental lysine as the cost-effective and nutritionally precise tool for optimizing the essential amino acid profile of compound poultry and swine feeds formulated on the ideal protein concept, which minimizes total dietary crude protein content and associated feed cost and environmental nitrogen excretion by supplementing specific limiting amino acids at levels precisely matching animal requirements. Continuous fermentation strain improvement programs at major amino acid producers including Ajinomoto, CJ CheilJedang, and ADM have progressively increased the lysine yield from carbohydrate substrate, improved fermentation productivity per unit of reactor volume, and reduced the energy intensity of downstream processing, driving sustained long-term declines in lysine production cost that have made supplemental lysine increasingly cost-effective relative to high-protein feed ingredients and expanded the addressable market for lysine in compound feed formulations globally.

Plant Capacity and Production Scale:

The proposed lysine production facility is designed with an annual production capacity of approximately 100,000 tons, enabling economies of scale while maintaining operational flexibility across lysine monohydrochloride at minimum L-lysine assay for compound feed manufacturing and specialty nutrition applications requiring high-purity crystalline lysine, and lysine sulfate at 65% minimum L-lysine assay for direct incorporation into feed premix and complete feed formulations at lower cost per unit of lysine content. This production range supports supply to both large-scale integrated poultry and swine feed manufacturers and amino acid trading companies requiring consistent, high-volume lysine supply with full product analysis certification, amino acid assay documentation, and microbiological quality compliance declarations, and specialty customers requiring food-grade lysine monohydrochloride for human food fortification applications, pharmaceutical-grade lysine for clinical nutrition formulations, and application-specific lysine product forms for nutraceutical supplement and functional food ingredient markets.

Speak to an Analyst for Customized Report: https://www.imarcgroup.com/request?type=report&id=22865&flag=C

Financial Viability and Profitability Analysis:

The lysine production business demonstrates healthy profitability potential under normal operating conditions. The financial projections reveal:

• Gross Profit: 25-35%

• Net Profit: 12-18%

These margins reflect the fermentation technology-intensive, carbohydrate substrate-dominated, and purification-process-dependent nature of lysine production, where glucose syrup or sucrose carbon sources are fermented by high-productivity Corynebacterium glutamicum strains through aerobic submerged batch or fed-batch fermentation, followed by cell separation, broth concentration, ion exchange chromatography or isoelectric crystallization purification, evaporation, spray drying or drum drying, and quality testing operations to produce specification-grade lysine monohydrochloride or lysine sulfate meeting stringent assay, optical rotation, heavy metals, microbiological, and moisture content requirements. Margins are supported by strong and consistent demand from compound feed manufacturers with growing livestock production volume providing offtake predictability; the progressive improvement in fermentation productivity and conversion yield driving sustainable production cost reduction that expands addressable market applications; the high technical and capital investment barriers to entry from large-scale fermentation infrastructure, proprietary high-yield strain development, and downstream purification process know-how creating meaningful competitive protection for established world-scale producers; and the growing demand for food-grade and pharmaceutical-grade lysine commanding significant purity premiums over standard feed-grade product. The project demonstrates solid return on investment (ROI) potential with comprehensive financial analysis covering income projections, expenditure projections, break-even points, net present value (NPV), internal rate of return, and detailed profitability and sensitivity analysis. Glucose syrup or sucrose substrate procurement cost management and fermentation titer, yield, and volumetric productivity optimization are the primary operational variables impacting margin performance.

Cost of Setting Up a Lysine Production Plant:

Operating Cost Structure:

The cost structure for a lysine production plant is primarily driven by:

• Raw Materials: 55-65% of total OpEx

• Utilities: 20-25% of OpEx

• Other Expenses: Including transportation, packaging, salaries and wages, depreciation, taxes, and other expenses

Raw materials - particularly glucose syrup from corn wet milling or dextrose from starch hydrolysis as the primary fermentable carbon source providing the carbon skeleton and energy for Corynebacterium glutamicum lysine biosynthesis, or raw sugar (sucrose) from sugarcane or sugar beet processing as an alternative carbon substrate, along with ammonia or ammonium sulfate as the nitrogen source for amino acid and biomass synthesis, corn steep liquor or yeast extract as nitrogen and growth factor supplements, and inorganic mineral salts including magnesium sulfate, potassium phosphate, and trace metals for fermentation media formulation account for approximately 55-65% of total operating expenses, making glucose syrup or sucrose procurement strategy, carbohydrate supplier qualification, and long-term supply contract management the central raw material cost management priorities. Carbon source quality, purity, glucose content, fermentable sugar concentration, and inhibitor compound levels critically impact fermentation strain performance, lysine titer achievable, and fermentation cycle time, with carbohydrate feedstock quality directly affecting achievable volumetric productivity, overall lysine yield per ton of sugar consumed, and downstream purification process efficiency and finished product quality. Utilities represent a notably high 20-25% of OpEx, driven by the energy-intensive aerobic fermentation bioreactor agitation and aeration compressor loads, steam sterilization and CIP operations, evaporation and concentration energy requirements, spray drying or drum drying energy consumption, ion exchange resin regeneration chemical and energy costs, and the significant electricity and process water consumption of continuous large-scale amino acid fermentation and purification operations. In the first year of operations, costs cover raw materials, utilities, depreciation, taxes, packing, transportation, and repairs and maintenance. By the fifth year, total operational cost is expected to increase due to inflation, market fluctuations, and potential rises in carbohydrate substrate and ammonia prices, with supply chain disruptions and shifts in global livestock feed amino acid pricing cycles also contributing to cost variation.

Capital Investment Requirements:

Setting up a lysine production plant requires significant capital investment across fermentation media preparation and sterilization, large-scale aerobic fermentation, cell separation, broth purification, evaporation and concentration, crystallization or spray drying, and quality testing infrastructure. The total capital investment depends on plant capacity, fermentation and purification technology, automation level, and location, covering land acquisition, site preparation, and amino acid biomanufacturing infrastructure meeting all applicable food safety, environmental, and quality compliance requirements.

Land and Site Development: The location must offer reliable access to glucose syrup or sucrose from corn wet milling plants, sugarcane mills, or starch hydrolysis facilities as the primary fermentation carbon substrate, ammonia or ammonium sulfate from nitrogen chemical suppliers, corn steep liquor from corn wet mills as a cost-effective nitrogen and growth factor source, and packaging materials from polypropylene bag and bulk bag suppliers, along with proximity to target markets including compound feed manufacturers, amino acid trading companies, and specialty food and pharmaceutical ingredient distributors to minimize logistics costs for bulk or bagged lysine product delivered to feed mill customers throughout agricultural production regions. The site must have reliable high-capacity electrical power for fermentation bioreactor agitation, aeration compressors, and spray dryer operation, adequate clean steam supply for fermentation media sterilization and CIP operations, high-purity process water for fermentation media preparation and equipment cleaning, reliable road logistics access for carbohydrate substrate tanker truck delivery and lysine product outbound distribution, and specialized effluent treatment systems for fermentation broth and ion exchange regenerant waste streams. Compliance with food safety management system certification requirements for food-grade lysine production, feed safety regulations including applicable national feed additive registration and quality standard compliance, environmental permits for biological fermentation effluent treatment and ammonia emission control, and REACH chemical substance notification requirements where applicable must be ensured.

Machinery and Equipment: Equipment costs for fermentation bioreactors, evaporators, and spray dryers represent the largest capital expenditure categories. High-quality, stainless steel, GMP-compatible machinery designed for large-scale amino acid fermentation must be selected. Essential equipment includes:

• Fermentation media preparation and sterilization systems - glucose syrup or sucrose receiving and storage tanks with metering and dilution systems, media mixing vessels for preparation of complete fermentation medium incorporating carbon source, nitrogen source, mineral salts, and growth factors at specified concentrations, and continuous or batch sterilization systems using high-temperature short-time (HTST) or direct steam injection sterilization for destruction of contaminating microorganisms before inoculation

• Seed fermenters - small-scale inoculum development fermenters for sequential scale-up of Corynebacterium glutamicum working cell bank culture from shake flask through seed fermenter stages at controlled temperature, pH, dissolved oxygen, and aeration conditions, achieving target viable cell density and metabolic activity for inoculation of production fermenters with high-performance lysine-producing seed culture

• Production fermenters - large-scale stainless steel stirred-tank bioreactors with jacket and coil temperature control, sparger aeration systems, mechanical agitators, dissolved oxygen and pH monitoring and control, foam control systems, and automated fed-batch glucose and ammonia feeding systems for controlled aerobic batch or fed-batch fermentation of Corynebacterium glutamicum at optimized temperature, pH, dissolved oxygen, and nutrient feeding profiles achieving target lysine titer of 100 to 180 grams per liter over 40 to 60 hour fermentation cycles

• Cell separation systems - high-speed disc-stack centrifuges or cross-flow membrane microfiltration systems for separation of Corynebacterium glutamicum cell biomass from lysine-containing fermentation broth, producing clarified lysine broth at target cell turbidity and biomass removal efficiency for downstream purification processing, with biomass recycled as animal feed ingredient or composted for agricultural use

• Evaporators and concentration systems - multi-effect falling film or forced circulation evaporators for concentration of clarified lysine broth from fermentation titer to higher lysine concentration suitable for direct spray drying as lysine sulfate product, or for reduction of water content before ion exchange purification and crystallization for lysine monohydrochloride production, with energy-efficient vapor recompression or multiple-effect heat integration for steam economy improvement

• Ion exchange purification systems - cation exchange resin columns for selective adsorption of lysine from fermentation broth and elution with acid or ammonia for production of purified lysine solution at specified purity and assay suitable for crystallization into food-grade or pharmaceutical-grade lysine monohydrochloride, with resin regeneration systems and regenerant waste neutralization and disposal infrastructure

• Crystallizers - batch or continuous crystallization vessels with controlled cooling or anti-solvent addition for nucleation and growth of L-lysine monohydrochloride crystals from concentrated purified lysine solution at specified supersaturation, temperature profile, and crystal habit control conditions, producing lysine monohydrochloride crystals at target particle size, purity, and optical purity specifications for feed-grade and food-grade product grades

• Centrifuges and washing systems - pusher or peeler centrifuges for separation of lysine monohydrochloride crystals from mother liquor at controlled G-force and centrifugation conditions achieving target crystal moisture content and residual impurity level, with crystal washing capability for removal of surface impurities and achievement of color and assay specifications for high-purity lysine monohydrochloride product grades

• Spray dryers and drum dryers - spray drying systems for conversion of concentrated lysine sulfate broth into free-flowing powder by atomization and hot air drying at controlled inlet temperature, atomizer speed, and outlet moisture specifications for lysine sulfate product, or fluid bed or drum dryers for moisture removal from centrifuged lysine monohydrochloride crystals to target finished product moisture content and free-flowing handling characteristics

• Quality testing and analytical equipment - HPLC amino acid analyzers for L-lysine assay and optical purity determination, Karl Fischer moisture analyzers, heavy metal testing equipment by ICP-OES, microbiological testing incubators and media for total plate count and Salmonella absence verification, color measurement spectrophotometers, and bulk density and particle size analyzers for comprehensive finished lysine product quality specification compliance and batch release testing

All equipment must comply with applicable food manufacturing and animal feed additive GMP requirements, stainless steel hygienic design standards for product-contact surfaces, and environmental management system requirements for fermentation effluent treatment and ammonia emission control. ISO 9001 or FSSC 22000 quality management system certification, applicable national feed additive registration and quality standard compliance for feed-grade lysine supply, food additive approval including GRAS status for food-grade applications, and compliance with major compound feed manufacturer supplier qualification audit requirements are standard prerequisites for commercial lysine supply to global animal nutrition and specialty application customers.

The fermentation strain productivity, expressed as lysine titer and yield from carbohydrate substrate, is the single most critical technical and economic performance parameter determining the competitiveness of any lysine production operation in the global amino acid commodity market.

Civil Works: Building construction and plant layout optimized for GMP-compatible fermentation manufacturing workflow, containment of fermentation organism, and amino acid manufacturing quality compliance across carbohydrate substrate receiving and storage, media preparation and sterilization, seed fermenter and production fermenter halls, cell separation and broth clarification, purification and concentration, crystallization, drying and finishing, quality control laboratory, packaging, and finished product warehouse areas. Dedicated fermenter halls with positive pressure HVAC and controlled access for contamination prevention, stainless steel and epoxy-coated flooring in product-contact areas, validated CIP and SIP systems for all fermentation and downstream processing equipment, and specialized effluent treatment for fermentation broth containing biomass, amino acids, and inorganic salts are essential lysine production facility quality, environmental, and operational compliance requirements.

Other Capital Costs: Costs associated with land acquisition, construction, and utilities including electrical substation for fermentation bioreactor agitation, aeration compressor, and spray dryer loads, clean steam generation and distribution system for media sterilization and CIP operations, high-purity water treatment and distribution systems for fermentation media preparation and equipment washing, compressed air systems for instrumentation and pneumatic equipment, ammonia storage and metering systems for fermentation pH control and nitrogen supply, ion exchange resin initial inventory for purification system loading, and biological effluent treatment plant for fermentation broth and process wastewater biological treatment before discharge must be considered in the financial plan. Pre-operative expenses including quality management system development and certification, feed additive product registration applications in target markets, food additive GRAS notification or regulatory submission where food-grade product is targeted, fermentation strain scale-up from laboratory to production scale validation, process optimization trials for fermentation productivity and downstream purification yield, and operator microbial fermentation, amino acid processing, and food safety quality management training programs are important components of total project investment planning.

Buy Now: https://www.imarcgroup.com/checkout?id=22865&method=2175

Major Applications and Market Segments:

Lysine production outputs serve critical amino acid nutrition, protein quality optimization, environmental sustainability, and human health functions across the global animal feed, food and beverage, pharmaceutical, and nutraceutical sectors:

Animal Feed Industry: The animal feed sector is by far the largest consumer of lysine, with supplemental L-lysine monohydrochloride and lysine sulfate extensively incorporated into compound poultry and swine feed formulations at inclusion levels of 2 to 5 grams per kilogram of complete feed to supplement the lysine deficiency in cereal-based diets dominated by maize and sorghum that contain lysine concentrations substantially below the ideal protein requirements of fast-growing broiler chickens, turkey poults, and finishing pigs. Lysine supplementation enables compound feed manufacturers to formulate on the ideal protein concept, precisely balancing dietary essential amino acid supply to match commercial livestock genetic requirements while reducing total crude protein content of the diet by 2 to 4 percentage points, generating significant savings in expensive high-protein ingredients including soybean meal and fishmeal while simultaneously reducing fecal nitrogen excretion and ammonia emissions from animal housing by 10 to 20% - a growing regulatory compliance and environmental sustainability imperative for commercial livestock producers in regulated agricultural markets.

Food and Beverage Industry: Food-grade L-lysine monohydrochloride is used as a nutritional fortifier in processed grain-based food products including bread, pasta, instant noodles, breakfast cereals, and energy bars to improve the amino acid balance and functional protein quality of cereal-based foods where lysine is the first-limiting amino acid, enhancing the biological value of plant protein consumed by populations relying primarily on cereal staple foods for dietary protein intake. The food fortification application commands a significant purity and safety documentation premium over feed-grade lysine, as food-grade product must meet strict food additive regulatory approval requirements and comprehensive food safety testing protocols that justify the higher selling price achievable in food industry channels relative to commodity feed-grade supply.

Pharmaceutical Industry: Lysine is used in pharmaceutical formulations as an active ingredient or excipient in clinical nutrition amino acid infusion products for parenteral and enteral nutrition of hospitalized patients with elevated protein requirements, antiviral treatment protocols where lysine supplementation has been demonstrated to reduce the frequency and severity of herpes simplex virus outbreak episodes, wound healing and tissue repair therapeutic supplements for post-surgical and burn injury patient nutrition, and as a carrier or stabilizing excipient in certain drug formulation systems. The pharmaceutical application represents the highest-value market for lysine, with parenteral-grade pharmaceutical lysine commanding prices multiple times above commodity feed-grade lysine reflecting the extremely stringent sterility, endotoxin, heavy metals, and amino acid assay specifications required for intravenous administration products.

Nutraceutical Sector: Lysine is widely used in dietary supplement formulations including amino acid complex capsules and tablets, sports nutrition protein powders and recovery supplements, collagen synthesis support formulations combining lysine with proline and vitamin C, immune support supplements targeting herpes virus management and general immune function, and bone health formulations where lysine's role in calcium absorption and collagen cross-linking provides complementary nutritional benefits alongside calcium and vitamin D ingredients. The nutraceutical and sports nutrition markets represent growing premium segments for high-purity lysine ingredients where brand differentiation, clean label ingredient positioning, and documented clinical benefits support pricing premiums relative to commodity feed-grade supply levels.

Why Invest in Lysine Production?

Several compelling strategic and commercial factors make lysine production an attractive investment:

Growing Demand for Animal Protein: Rising global meat consumption is the most fundamental and structurally durable driver of lysine demand, with the continuing dietary transition of emerging market populations toward higher animal protein intake creating decades-long demand growth for commercial poultry and swine production that directly and proportionally drives demand for supplemental lysine in compound feed formulations. The shift of protein consumption in densely populated emerging markets including China, India, Southeast Asia, and Sub-Saharan Africa from predominantly plant-based to increasingly animal-protein-based dietary patterns represents the most significant and sustained structural demand growth driver for amino acid feed additives in the global specialty fermentation industry, providing long-term revenue visibility for producers strategically positioned in or near these high-growth regional livestock production markets.

Advancements in Fermentation Technology: Continuous improvements in Corynebacterium glutamicum metabolic engineering and adaptive laboratory evolution are enabling progressive increases in lysine titer, yield from carbohydrate substrate, and fermentation productivity that reduce the per-unit production cost of lysine and improve the economics of new capacity investments. Synthetic biology approaches including genome-scale metabolic modeling, CRISPR-based gene editing for flux redirection toward the lysine biosynthetic pathway, and high-throughput screening of mutant strain libraries are accelerating the rate of strain performance improvement available to producers investing in proprietary fermentation strain development programs, creating meaningful technical differentiation opportunities relative to producers relying on commercially available or licensed strains.

Expanding Feed Industry: The rapid growth of the commercial livestock sector globally, driven by rising protein consumption in emerging economies, the progressive formalization of smallholder farming into integrated commercial production systems, and the adoption of precision livestock nutrition programs by technically advanced integrated producers, is boosting demand for essential amino acid supplements including lysine across all major livestock species and production systems. The aquaculture sector's rapid expansion into high-value marine and freshwater fish and shrimp production systems using compound feed formulations is creating an additional and rapidly growing demand segment for supplemental lysine in fish and shrimp feed where plant protein ingredient-based diets require amino acid supplementation to meet the specific essential amino acid requirements of different aquaculture species.

Sustainability Benefits: Lysine supplementation enables animal producers to reduce total dietary crude protein content in compound feed formulations by replacing expensive high-protein ingredients with lower-protein cereals supplemented with synthetic amino acids, generating significant environmental benefits through reduced fecal and urinary nitrogen excretion by livestock and lower ammonia emissions from animal housing and manure management systems that contribute to air quality and water body eutrophication challenges in intensive livestock production regions. The growing regulatory pressure on livestock sector environmental nitrogen management in the European Union, North America, and emerging market economies implementing environmental agricultural regulations is creating a compliance-driven demand driver for lysine supplementation programs that deliver documented nitrogen excretion reduction benefits measurable in environmental impact assessments and farm environmental permit compliance reporting.

Scalable and High-Volume Production: Large-scale aerobic fermentation processes for lysine production support efficient capacity scaling through modular addition of fermentation bioreactor volume and downstream processing capacity with proportionate capital investment, enabling operators to grow manufacturing output in line with market demand development without requiring complete facility reconstruction. The continuous improvement trajectory of fermentation strain productivity and downstream processing efficiency provides established lysine producers with a clear operational improvement pathway delivering progressive reduction in production cost per tonne of lysine over successive operating years, creating a compounding competitive cost advantage for producers investing in ongoing fermentation strain development and process optimization programs relative to producers relying on static production technology.

Manufacturing Process Excellence:

The lysine production process involves raw material preparation, fermentation media sterilization, seed culture scale-up, aerobic fed-batch fermentation, cell separation, broth purification, concentration, crystallization or spray drying, quality inspection, and packaging. The main production steps include:

• Raw material receiving and fermentation media preparation - glucose syrup or sucrose receiving and quality verification for fermentable sugar content, purity, and inhibitor compound levels, followed by preparation of complete fermentation medium by dissolution and mixing of carbon source, ammonia nitrogen, mineral salts, corn steep liquor, and trace metal micronutrients at specified concentrations in media preparation vessels with sterilization by continuous HTST or batch in-situ steam sterilization

• Seed culture preparation and scale-up - sequential scale-up of Corynebacterium glutamicum high-lysine-producing strain from frozen working cell bank vial through shake flask, laboratory fermenter, and seed fermenter stages at controlled temperature, pH, dissolved oxygen, and aeration conditions, achieving target cell density, growth rate, and metabolic activity for transfer of high-performance inoculum to production fermenters at 5 to 10% inoculation volume

• Aerobic fed-batch fermentation - controlled aerobic fed-batch fermentation of Corynebacterium glutamicum in production bioreactors at optimized temperature of 30 to 37 degrees Celsius, pH of 6.5 to 7.5 controlled by ammonia addition, dissolved oxygen above 20% saturation maintained by agitation and aeration rate control, and programmed glucose and ammonia fed-batch feeding strategies to maintain carbon and nitrogen substrate at growth-limiting but non-inhibitory concentrations for maximum lysine productivity and yield over 40 to 60 hour fermentation cycles achieving target lysine titers of 100 to 180 grams per liter

• Cell biomass separation - disc-stack centrifugation or cross-flow microfiltration membrane separation of Corynebacterium glutamicum cell biomass from lysine-containing fermentation broth at controlled separation efficiency, producing clarified lysine broth suitable for downstream purification with biomass residue processed for animal feed ingredient application or biological waste treatment

• Broth concentration and purification - multiple-effect evaporation of clarified lysine broth for direct concentration of lysine sulfate product to target solids content for spray drying, or ion exchange cation resin column purification of dilute lysine broth for selective lysine adsorption from fermentation impurities, followed by elution with dilute acid or ammonia to produce purified lysine solution of specified purity for crystallization into lysine monohydrochloride

• Crystallization - controlled batch crystallization of concentrated purified lysine monohydrochloride solution by temperature reduction or evaporative concentration under vacuum, nucleation induction, and crystal growth at controlled supersaturation and cooling rate profiles to produce L-lysine monohydrochloride crystals at target particle size distribution, purity, and optical rotation specifications for feed-grade and food-grade commercial product requirements

• Centrifugation, washing, and drying - pusher or peeler centrifuge separation of lysine monohydrochloride crystals from mother liquor with optional washing water addition for surface impurity removal, achieving target crystal moisture content, color, and assay purity, followed by fluidized bed or drum drying to remove residual surface moisture to below 1.0% water content specification for free-flowing finished product storage and handling

• Spray drying (for lysine sulfate) - atomization of concentrated lysine sulfate broth by rotary or two-fluid nozzle atomizer into heated drying chamber at controlled inlet air temperature of 150 to 200 degrees Celsius, chamber residence time, and outlet temperature to produce free-flowing lysine sulfate powder at target 65% minimum assay, moisture content, bulk density, and particle size specifications for direct incorporation into compound feed premix and complete feed formulations

• Quality inspection, certification, and dispatch - comprehensive product specification testing including L-lysine assay by HPLC, moisture content by Karl Fischer, optical rotation, heavy metals by ICP-OES, pH, color, microbiological plate count and Salmonella absence per applicable feed or food quality standards, bulk density and particle size analysis, with batch acceptance against product specification, certificate of analysis preparation, feed additive or food additive compliance documentation, and packaging in 25 kg bags or 500 kg bulk bags with full batch traceability for distribution to compound feed manufacturers and specialty nutrition ingredient customers

The complete process flow encompasses unit operations involved, mass balance and raw material requirements, quality assurance criteria, and technical tests throughout production. Quality management system records, fermentation batch records with time-temperature profiles, dissolved oxygen and pH logs, and lysine titer monitoring data, raw material incoming quality certificates, downstream purification process records, crystallization batch records, finished product batch analysis data and release certificates, and full product traceability from carbon substrate lot to finished lysine product batch and customer delivery must be maintained throughout all production stages. Regular compound feed manufacturer supplier qualification audit visits and national feed regulatory authority inspection readiness are standard operating requirements for commercial lysine supply to global animal nutrition customers.

Industry Leadership:

The global lysine industry is served by a small number of large-scale integrated amino acid fermentation companies with proprietary high-yield fermentation strain technology and established global compound feed and amino acid trading company customer relationships. Key industry players include:

• Global Bio-chem Technology Group Company Limited
• Ajinomoto Co. Ltd.
• Cheil Jedang Corp
• ADM
• Evonik
• COFCO Biochemical

These companies serve diverse end-use sectors including the animal feed industry, the food and beverage industry, the pharmaceutical industry, and the nutraceutical sector, with leading players investing continuously in fermentation strain metabolic engineering for titer and yield improvement, fermentation process automation and real-time optimization, downstream purification efficiency enhancement, production capacity expansion in proximity to growing livestock production markets in Asia and Latin America, and product portfolio diversification into higher-value food-grade and pharmaceutical-grade lysine to capture premium segment pricing opportunities above commodity feed-grade market levels.

Recent Industry Developments:

March 2026: Shanghai Henlius Biotech advanced oncology innovation following NMPA clearance for HLX97, an oral small molecule inhibitor targeting lysine acetyltransferase 6A/B (KAT6A/B) for advanced or metastatic solid tumors. The candidate demonstrates strong selectivity, favorable pharmacokinetics, and reduced hematologic toxicity versus comparators, supporting breast cancer and broader tumor applications, highlighting the growing pharmaceutical relevance of lysine-targeting therapeutic approaches and the expanding role of lysine chemistry in drug discovery beyond conventional amino acid nutrition applications.

April 2025: Eurolysine, a subsidiary of Avril Group, initiated a feasibility study targeting the expansion of amino acid production capacity within the European Union. The initiative focuses on strengthening regional supply chains, reducing import dependence on Asian lysine producers, and supporting feed and food sector demand within Europe with domestically produced lysine. Strategic evaluation covers technical, economic, and environmental parameters aligned with sustainability objectives and EU food and feed supply chain resilience policy priorities, reinforcing long-term commitment to European lysine production capacity development.

Browse Full Report: https://www.imarcgroup.com/lysine-manufacturing-plant-project-report

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company excels in understanding its client's business priorities and delivering tailored solutions that drive meaningful outcomes. We provide a comprehensive suite of market entry and expansion services. Our offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: (D) +91 120 433 0800
United States: (+1-201-971-6302)

This release was published on openPR.